Wharton Healthcare Conference to Be Headlined by CEOs of Eli Lilly and Aledade

Share Article

Former CMS administrator Mark McClellan to debate/discuss 2016 presidential election and implications for healthcare innovators with Elisabeth Rosenthal of the New York Times.

More than 500 will convene for night and day of debates about an industry in transition

The Wharton Health Care Business Conference is the marquee event of the year for healthcare at Wharton -- bringing together more than 500 alumni, faculty, MBA students and industry leaders.

The 2016 conference will explore the challenges faced by early stage companies and established organizations alike in the race to adapt to the post-reform healthcare world.

With a presidential election in November and the future of U.S. healthcare in the balance, the 2016 Wharton Health Care Business Conference will bring together over 500 top healthcare leaders for a night and day of debates and discussions about what lies ahead for an industry in transformation. The conference, organized by MBA students of the University of Pennsylvania’s Wharton School, will be held February 18 – 19, 2016 at the Union League of Philadelphia.

Mainstage Features Include:

+ Keynotes by John Lechleiter, PhD, CEO, Eli Lilly & Company, and Farzad Mostashari, MD, Founder & CEO, Aledade, and former National Coordinator for Health IT for the Department of Health and Human Services

+ A capstone debate/discussion with Mark McClellan, MD, PhD, Director of the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University, and Elisabeth Rosenthal MD, Senior Correspondent for Healthcare and Economics, New York Times, on what lies ahead for healthcare policy in 2016 and beyond

+ Opening remarks by Tom Spann, Founder, Vice Chairman and COO, Accolade at the Thursday night alumni welcome reception

In addition to mainstage presenters, six executive panels will explore how the shifting competitive landscape pertains to particular industry sectors. Panels and panelists include:

+ "From Volume to Value: New Frontiers in Payer / Provider Collaboration" – Vivek Garipalli, Co-Founder and CEO of Clover Health and Griffin Myers MD, Founder of Oak Street Health

+ "Big vs. Small: The Race to Create the Next Blockbuster Therapeutics" – Maria Maccecchini PhD, President and CEO of QR Pharma and Jeffrey Marrazzo, Co-Founder and CEO of Spark Therapeutics

+ "Picking Winners in a Fast-Changing Market: Investing in Healthcare Innovation" – Adele Olivia, Co-Founder and Partner of 1315 Capital; Trevor Price, Founder and Managing Partner of Oxeon Partners; and Anna Haghgooie, Managing Director, Sandbox Industries

+ "Winning Hearts and Wallets: Helping Consumers Navigate Healthcare" – Veer Gidwaney, Co-Founder and CEO of Maxwell Health; Sally Poblete, Founder and CEO of Wellthie; and Grant Verstandig, Founder and CEO of Rally Health

+ "Getting Personal: Harnessing Analytics for New Patient Insights" – Joanne Burns, Chief Strategy Officer of Cerner and Bob Watson, President of NantHealth

+ "Putting Patients at the Center: The Race to Re-engineer How Care Is Delivered" – Nancy Gagliano, MD, Chief Medical Officer, CVS/MinuteClinic

Begun in 1995, the Wharton Health Care Business Conference is the marquee event of the year for healthcare at Wharton, bringing together 500-plus industry leaders, alumni, faculty and MBA students from every sector of healthcare, including payers, providers, biotech/pharma, healthcare technology and more. Entitled “The Innovation Game: The Race Between Entrants + Incumbents,” the 2016 conference will explore the challenges faced by early stage entrants and established organizations alike in the race to adapt to the post-reform world. To learn more, visit http://www.whcbc.org.

Media Contact: Bernie Zipprich (info(at)whcbc(dot)org), WHCBC Co-Chair for Marketing

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bernie Zipprich
Visit website